23 results
10-K
2022 FY
SCNI
Scinai Immunotherapeutics Ltd
17 Apr 23
Annual report
4:06pm
in the event of uninsured or inadequately insured loss or damage. Our ability to effectively recruit and retain qualified officers and directors could … to retain or recruit qualified officers and directors to manage the Company.
Recent disruptions in the financial markets and economic conditions could
424B5
SCNI
Scinai Immunotherapeutics Ltd
28 Dec 21
Prospectus supplement for primary offering
5:20pm
could be adversely affected in the event of uninsured or inadequately insured loss or damage. Our ability to effectively recruit and retain qualified … , we may not be able to retain or recruit qualified officers and directors to manage the Company.
Recent disruptions in the financial markets
424B5
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
Prospectus supplement for primary offering
6:22am
or inadequately insured loss or damage. Our ability to effectively recruit and retain qualified officers and directors could also be adversely affected if we … officers and directors. If we are unable to adequately insure our officers and directors, we may not be able to retain or recruit qualified officers
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
22 Nov 21
Report of Foreign Private Issuer
6:05am
that is competitive in the marketplace in which we recruit talent. The proposed Compensation Policy is structured to tie the compensation of each officer to BiondVax’s
424B5
94tyxj72t
1 Feb 21
Prospectus supplement for primary offering
5:08pm
424B5
0pvyrx
29 Jan 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
r1r5hdepfk ym9k990
2 Oct 20
Condensed Interim Financial Statements
12:00am
424B5
00kcp8hq85zx7rffqj
2 Oct 20
Prospectus supplement for primary offering
12:00am
POS AM
74z999
7 Jan 20
Prospectus update (post-effective amendment)
10:51am
F-1/A
mqo0s6u
7 Jun 19
Registration statement (foreign) (amended)
11:42am
F-1/A
fvk8oljyc5534zbh
6 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1/A
1jc 4gnhp1cy7y
30 May 19
Registration statement (foreign) (amended)
8:46am
F-1/A
ake44rh6 xv83tc14m
6 May 19
Registration statement (foreign) (amended)
10:03am
6-K
EX-99.1
qqsrlt11c hn
23 Apr 19
Notice of an Extraordinary General Meeting of Shareholders
6:18am
F-1
9270jjri
25 Mar 19
Registration statement (foreign)
4:08pm